NCT00724269

Completed

Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens C...

Alcon Research Source

Compare

Other study identifiers

Sponsor study identifier

SMA-08-04 / BP-08-01

Study Type

interventional

Actual enrollment (reported)

20

Locations

1 country

Sites

1

Timeline

Study Start

October 2009

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2011

Actual (reported)

Study Completion

July 2011

Actual (reported)

Brief Summary

The purpose of this study is to evaluate the corneal epithelium after soft contact lens wear and use of two marketed multi-purpose solutions.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 20 participants
Study completion date: July 2011
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
July 25, 2008
Actual (reported)
First Posted
July 29, 2008
Actual (reported)
Study Start
October 2009
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
July 2011
Actual (reported)
Study Completion
July 2011
Actual (reported)

Last Updated: October 1, 2012
Status Verified: November 2011
Last Update Submitted: September 28, 2012

Conditions

Contact Lens Wear

Keywords

Contact lens wearmulti-purpose solutioncorneal staining

Outcome Measures

Primary Outcomes (1)

Confocal microscopy analysis of Corneal Epithelium
2 weeks

Secondary Outcomes (2)

Patient comfort
2 weeks
Corneal Staining
2 weeks

Study Arms (2)

Opti Free RepliniSH

ACTIVE COMPARATOR

Opti Free RepliniSH

Device: OPTI-FREE RepleniSH

ReNu Multi-Plus

ACTIVE COMPARATOR

ReNu Multi-Plus

Device: ReNu MultiPlus MPS

Interventions

OPTI-FREE RepleniSHDevice

Multi-Purpose Solution for soft contact lenses

Opti Free RepliniSH

ReNu MultiPlus MPSDevice

Multi-Purpose Solution for soft contact lenses

ReNu Multi-Plus

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Successful contact lens wear on a daily wear basis
Wear contact lenses at least 8 hours/day

Sponsors & Collaborators

Alcon Research
Industrylead

Study Sites (1)

Contact Alcon Call Center for Study Locations

Fort Worth, Texas, 76134, United States

Enrollment

20 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: INVESTIGATOR
Purpose: SCREENING
Intervention Model: CROSSOVER
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 25, 2008

First Posted

July 29, 2008

Study Start

October 2009

Date type not reported

This date has not been verified as actual or estimated.

NCT01132287

An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness

Not ApplicableCompleted

NCT03537248

A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution

Not ApplicableCompleted

NCT01069237

Compliance and Contamination in Soft Contact Lens Wearers

Completed

NCT03897712

A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens

Not ApplicableCompleted

NCT04158466

A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens

Not ApplicableCompleted

NCT03897751

A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses

Not ApplicableCompleted

Vision correctable to at least 20/30

Normal Eyes

You may not qualify if:

Topical ocular medication use

Contact the study team to confirm eligibility.

Primary Completion

July 2011

Actual (reported)

Study Completion

July 2011

Actual (reported)

Last Updated

October 1, 2012

Record last verified: 2011-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00724269
Data provider: ClinicalTrials.gov
Source updated: 2012-10-01
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:33:06 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

Opti Free RepliniSH

ReNu Multi-Plus

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations